Table 2.
Summary of results obtained by radiofrequency ablation.
| Study | N | Lesion set | Type of AF and aetiology | Concomitant or lone surgery | Mean followup ± SD (months) | Freedom from AF at mean followup (%) | Overall mortality at last f/u (%) |
|---|---|---|---|---|---|---|---|
| Srivastava et al., 2008 [16] | 160 | Overall | Persistent >3 months Rheu matic | Concomitant | 40 | ||
| 40 | Biatrial | 62.5 | 10 | ||||
| 40 | LA only | 57.5 | 7.5 | ||||
| 40 | PVI | 67.5 | 10 | ||||
| 40 | None | 20.0 | 5 | ||||
| Wang et al., 2009 [17] | 299 | Overall | Permanent | Concomitant | 28 ± 5 | 85.0 | 2.3 |
| 149 | LA+ cavotricuspid | 85.2 | 1.3 | ||||
| 150 | Biatrial | 84.1 | 4.7 | ||||
| Chiappini et al., 2004 [18] | 40 | CM III | Chronic | Concomitant | 16.5 ± 2.5 | 88.5 at last f/u | 7.5 |
| Beukema et al., 2008 [19] | 285 | Modified Maze (biatrial) | Permanent | Concomitant | 43.6 ± 25.4 | 57.1 at last f/u | 27.4% |
| Topkara et al., 2006 [20] |
Endocardial 82.9% epicardial 17.1%. Variable lesion set |
Paroxysmal | Concomitant and Lone | Last f/u 24 months | 75.3 | Not specified for RF only | |
| 168 | Persistent | ||||||
| Lone | |||||||